These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 21286242)
1. Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice. Bastianini S; Silvani A; Berteotti C; Elghozi JL; Franzini C; Lenzi P; Lo Martire V; Zoccoli G Sleep; 2011 Feb; 34(2):213-8. PubMed ID: 21286242 [TBL] [Abstract][Full Text] [Related]
2. Control of cardiovascular variability during undisturbed wake-sleep behavior in hypocretin-deficient mice. Silvani A; Bastianini S; Berteotti C; Lo Martire V; Zoccoli G Am J Physiol Regul Integr Comp Physiol; 2012 Apr; 302(8):R958-64. PubMed ID: 22357806 [TBL] [Abstract][Full Text] [Related]
3. Effects of ambient temperature on sleep and cardiovascular regulation in mice: the role of hypocretin/orexin neurons. Lo Martire V; Silvani A; Bastianini S; Berteotti C; Zoccoli G PLoS One; 2012; 7(10):e47032. PubMed ID: 23056568 [TBL] [Abstract][Full Text] [Related]
4. Sleep and cardiovascular phenotype in middle-aged hypocretin-deficient narcoleptic mice. Silvani A; Bastianini S; Berteotti C; Cenacchi G; Leone O; Lo Martire V; Papa V; Zoccoli G J Sleep Res; 2014 Feb; 23(1):98-106. PubMed ID: 24033681 [TBL] [Abstract][Full Text] [Related]
5. Behavioral state instability in orexin knock-out mice. Mochizuki T; Crocker A; McCormack S; Yanagisawa M; Sakurai T; Scammell TE J Neurosci; 2004 Jul; 24(28):6291-300. PubMed ID: 15254084 [TBL] [Abstract][Full Text] [Related]
6. Autonomic mechanisms of blood pressure alterations during sleep in orexin/hypocretin-deficient narcoleptic mice. Alvente S; Berteotti C; Bastianini S; Lo Martire V; Matteoli G; Silvani A; Zoccoli G Sleep; 2021 Jul; 44(7):. PubMed ID: 33517440 [TBL] [Abstract][Full Text] [Related]
7. High-amplitude theta wave bursts during REM sleep and cataplexy in hypocretin-deficient narcoleptic mice. Bastianini S; Silvani A; Berteotti C; Lo Martire V; Zoccoli G J Sleep Res; 2012 Apr; 21(2):185-8. PubMed ID: 21883592 [TBL] [Abstract][Full Text] [Related]
8. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602 [TBL] [Abstract][Full Text] [Related]
9. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function. Tabuchi S; Tsunematsu T; Black SW; Tominaga M; Maruyama M; Takagi K; Minokoshi Y; Sakurai T; Kilduff TS; Yamanaka A J Neurosci; 2014 May; 34(19):6495-509. PubMed ID: 24806676 [TBL] [Abstract][Full Text] [Related]
11. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice. Fujiki N; Cheng T; Yoshino F; Nishino S Exp Neurol; 2009 May; 217(1):46-54. PubMed ID: 19416673 [TBL] [Abstract][Full Text] [Related]
12. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. Zhang S; Zeitzer JM; Sakurai T; Nishino S; Mignot E J Physiol; 2007 Jun; 581(Pt 2):649-63. PubMed ID: 17379635 [TBL] [Abstract][Full Text] [Related]
13. Lack of hypocretin attenuates behavioral changes produced by glutamatergic activation of the perifornical-lateral hypothalamic area. Kostin A; Siegel JM; Alam MN Sleep; 2014 May; 37(5):1011-20. PubMed ID: 24790280 [TBL] [Abstract][Full Text] [Related]
14. Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. Grimaldi D; Calandra-Buonaura G; Provini F; Agati P; Pierangeli G; Franceschini C; Barletta G; Plazzi G; Montagna P; Cortelli P Sleep; 2012 Apr; 35(4):519-28. PubMed ID: 22467990 [TBL] [Abstract][Full Text] [Related]
15. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957 [TBL] [Abstract][Full Text] [Related]
16. Abnormal sleep/wake dynamics in orexin knockout mice. Diniz Behn CG; Klerman EB; Mochizuki T; Lin SC; Scammell TE Sleep; 2010 Mar; 33(3):297-306. PubMed ID: 20337187 [TBL] [Abstract][Full Text] [Related]
17. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice. Sagawa Y; Sato M; Sakai N; Chikahisa S; Chiba S; Maruyama T; Yamamoto J; Nishino S Neuropharmacology; 2016 Nov; 110(Pt A):268-276. PubMed ID: 27474349 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive detection of sleep/wake changes and cataplexy-like behaviors in orexin/ataxin-3 transgenic narcoleptic mice across the disease onset. Sato M; Sagawa Y; Hirai N; Sato S; Okuro M; Kumar S; Kanbayashi T; Shimizu T; Sakai N; Nishino S Exp Neurol; 2014 Nov; 261():744-51. PubMed ID: 25118620 [TBL] [Abstract][Full Text] [Related]
20. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep. Roman A; Meftah S; Arthaud S; Luppi PH; Peyron C Sleep; 2018 Jun; 41(6):. PubMed ID: 29522212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]